Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat

Journal of Neuroscience Methods

Volumn 142, Issue 1, 2005, Pages 115-124

  Gozzi, Alessandro ^a   Schwarz, Adam J ^a   Reese, Torsten ^a   Crestan, Valerio ^a   Bertani, Simone ^a   Turrini, Giuliano ^a   Corsi, Mauro ^a   Bifone, Angelo ^a  

^a GSK   (Italy)

Author keywords

GR 73632; ICV; NK1 receptor agonist; phMRI; Rat; rCBV

Indexed keywords

5 AMINOVALERYLSUBSTANCE P [7-11][9 PROLINE 10 (N METHYLLEUCINE)]; NEUROPEPTIDE; SUPERPARAMAGNETIC IRON OXIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN BLOOD VOLUME; BRAIN CORTEX; BRAIN MAPPING; CAUDATE NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEASIBILITY STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; RAT;

ANESTHETICS; ANIMALS; BRAIN; BRAIN MAPPING; CEREBROVASCULAR CIRCULATION; DRUG DELIVERY SYSTEMS; INJECTIONS, INTRAVENTRICULAR; LATERAL VENTRICLES; MAGNETIC RESONANCE IMAGING; MALE; NEUROPEPTIDES; NEUROPHARMACOLOGY; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 12344328409     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2004.08.013     Document Type: Article

References (53)

1. W.A. Banks, and A.J. Kastin Passage of peptides across the blood-brain barrier: pathophysiological perspectives Life Sci. 59 1996 1923 1943
2. M.J. Bier, J. Goldfarb, M. Orlowski, and S. Wilk Intracerebroventricular infusion of inhibitors of endopeptidase-24.11 ('enkephalinase') increases the spontaneous firing frequency of an identifiable set of cells in the substantia nigra Eur. J. Pharmacol. 142 1987 321 330
3. E. Cellier, L. Barbot, S. Iyengar, and R. Couture Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat Br. J. Pharmacol. 127 1999 717 728
4. Q. Chen, A.H. Andersen, Z. Zhang, A. Ovadia, D.M. Gash, and M.J. Avison Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRI Magn. Reson. Imaging 14 1996 469 476
5. Y.-C.I. Chen, A.-L. Brownell, W. Galpern, O. Isacson, M. Bogdanov, and M.F. Beal Detection of dopaminergic cell loss and neural transplantation using pharmacological MRI, PET and behavioural assessment NeuroReport 10 1999 2881 2886
6. Y.C. Chen, W.R. Galpern, A.L. Brownell, R.T. Matthews, M. Bogdanov, and O. Isacson Detection of dopaminergic neurotransmitter activity using pharmacologic MRI: correlation with PET, microdialysis, and behavioral data Magn. Reson. Med. 38 1997 389 398
7. R.W. Cox, and J.S. Hyde Software tools for analysis and visualization of fMRI data NMR Biomed. 10 1997 171 178
8. R.J. Davidson, H. Abercrombie, J.B. Nitschke, and K. Putnam Regional brain function, emotion and disorders of emotion Curr. Opin. Neurobiol. 9 1999 228 234
9. N. Doi, C.H. Brown, H.D. Cohen, G. Leng, and J.A. Russell Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro Br. J. Pharmacol. 132 2001 1136 1144
10. D.J. Dusser, E. Umeno, P.D. Graf, T. Djokic, D.B. Borson, and J.A. Nadel Airway neutral endopeptidase-like enzyme modulates tachykinin-induced bronchoconstriction in vivo J. Appl. Physiol. 65 1988 2585 2591
11. P.J. Elliott, G.S. Mason, E.A. Graham, M.P. Turpin, and R.M. Hagan Modulation of the rat mesolimbic dopamine pathway by neurokinins Behav. Brain Res. 51 1992 77 82
12. P.J. Elliott, G.S. Mason, M. Stephens-Smith, and R.M. Hagan Behavioural and biochemical responses following activation of midbrain dopamine pathways by receptor selective neurokinin agonists Neuropeptides 19 1991 119 126
13. S. Endo, H. Yokosawa, and S. Ishii Purification and characterization of a substance P-degrading endopeptidase from rat brain J. Biochem. (Tokyo) 104 1988 999 1006
14. S. Erhardt, and G. Engberg Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate Life Sci. 67 2000 1901 1911
15. C.R. Genovese, N.A. Lazar, and T. Nichols Thresholding of statistical maps in functional neuroimaging using the false discovery rate NeuroImage 15 2002 870 878
16. J.F. Ghersi-Egea, W. Finnegan, J.L. Chen, and J.D. Fenstermacher Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat Neuroscience 75 1996 1271 1288
17. A. Gozzi, A.J. Schwarz, T. Reese, V. Crestan, S. Bertani, and G. Turrini Brain functional imaging of intracerebroventricular injection of corticotropin-releasing factor (CRF) in the anaesthetised rat Proceedings of the 12th ISMRM Scientific Meeting and Exhibition on Book of Abstracts, vol. 12 Kyoto, Japan 2004 226
18. A.J. Greenshaw Electrical and Chemical Stimulation of Brain Tissue in Vivo, vol. 32 1998 In Vivo Neuromethods Humana Press Totowa
19. J. Haffmans, Y.J. Blankwater, O.E. Ukponmwan, F.J. Zijlstra, J.E. Vincent, and W. Hespe Correlation between the distribution of 3H-labelled enkephalin in rat brain and the anatomical regions involved in enkephalin-induced seizures Neuropharmacology 22 1983 1021 1028
20. R.M. Hagan, S.J. Ireland, C.C. Jordan, I.J. Beresford, M.J. Deal, and P. Ward Receptor-selective, peptidase-resistant agonists at neurokinin NK-1 and NK-2 receptors: new tools for investigating neurokinin function Neuropeptides 19 1991 127 135
21. B. Horsthemke, M. Schulz, and K. Bauer Degradation of substance P by neurones and glial cells Biochem. Biophys. Res. Commun. 125 1984 728 733
22. G.C. Houston, N.G. Papadakis, T.A. Carpenter, L.D. Hall, B. Mukherjee, and M.F. James Mapping of brain activation in response to pharmacological agents using fMRI in the rat Magn. Reson. Imaging 19 2001 905 919
23. Y. Kagamiishi, T. Yamamoto, and S. Watanabe Hippocampal serotonergic system is involved in anxiety-like behavior induced by corticotropin-releasing factor Brain Res. 991 2003 212 221
24. F. Lejeune, and M.J. Millan The CRF1 receptor antagonist, DMP695, abolishes activation of locus coeruleus noradrenergic neurones by CRF in anesthetized rats Eur. J. Pharmacol. 464 2003 127 133
25. H. Maeno, H. Kiyama, and M. Tohyama Distribution of the substance P receptor (NK-1 receptor) in the central nervous system Brain Res. 18 1993 43 58
26. J.B. Mandeville, B.G. Jenkins, B.E. Kosofsky, M.A. Moskowitz, B. Rosen, and J.J.A. Marota Regional sensitivity and coupling of BOLD and CBV changes during stimulation of rat brain Magn. Res. Med. 45 2001 443 447
27. J.B. Mandeville, J.J.A. Marota, B.E. Kosofsky, J.R. Keltner, R. Weissleder, and B. Rosen Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation Magn. Res. Med. 39 1998 615 624
28. P.W. Mantyh Neurobiology of substance P and the NK1 receptor J. Clin. Psychiat. 63 2002 6 10
29. J.J.A. Marota, J.B. Mandeville, R. Weisskoff, M.A. Moskowitz, B. Rosen, and B.E. Kosofsky Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat NeuroImage 11 2000 13 23
30. M. Monda, A. Viggiano, A. Sullo, and V.L. De Aspartic and glutamic acids increase in the frontal cortex during prostaglandin E1 hyperthermia Neuroscience 83 1998 1239 1243
31. R. Mongeau, B.M. De Oca, M.S. Fanselow, and C.A. Marsden Differential effects of neurokinin-1 receptor activation in subregions of the periaqueductal gray matter on conditional and unconditional fear behaviors in rats Behav. Neurosci. 112 1998 1125 1135
32. P.G. Morris Magnetic resonance imaging and magnetic resonance spectroscopy assessment of brain function in experimental animals and man J. Psychopharmacol. 13 1999 330 336
33. G. Nyitrai, I. Kovacs, E. Szarics, N. Skuban, G. Juhasz, and J. Kardos Role of intracellular Ca(2+) stores shaping normal activity in brain J. Neurosci. Res. 57 1999 906 915
34. S. Ogawa, R.S. Menon, D.W. Tank, S.G. Kim, H. Merkle, and J.M. Ellermann Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model Biophys. J. 64 1993 803 812
35. M.J. O'Neil, A. Smith, P.E. Heckelman, G.R. Obenchain, J.A.R. Gallipeau, and M. Ann D'Arecca Merck Index: An Encyclopedia of Chemicals, Drugs & Biologicals 2003 Merck & Co. Inc. Whitehouse Station, NJ, USA p. 1270-1271
36. G. Paxinos, and C. Watson The Rat Brain in Stereotactic Coordinates 1998 Academic Press San Diego
37. 14C]inulin in rat Neuroscience 95 2000 577 592
38. T. Reese, B. Bjelke, R. Porszasz, D. Baumann, D. Bochelen, and A. Sauter Regional brain activation by bicuculline visualized by functional magnetic resonance imaging. Time-resolved assessment of bicuculline-induced changes in local cerebral blood volume using an intravascular contrast agent NMR Biomed. 13 2000 43 49
39. N.M. Rupniak, E.J. Carlson, S. Shepheard, G. Bentley, A.R. Williams, and A. Hill Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608 Neuropharmacology 45 2003 231 241
40. M. Saffroy, J.C. Beaujouan, Y. Torrens, J. Besseyre, L. Bergstrom, and J. Glowinski Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain Peptides 9 1988 227 241
41. M. Saffroy, Y. Torrens, J. Glowinski, and J.-C. Beaujouan Autoradiographic distribution of tachykinin NK2 binding sites in the rat brain: comparison with NK1 and NK3 binding sites Neuroscience 116 2003 761 773
42. A. Saria The tachykinin NK1 receptor in the brain: pharmacology and putative functions Eur. J. Pharmacol. 375 1999 51 60
43. B.E. Scanley, R.P. Kennan, and J.C. Gore Changes in rat cerebral blood volume due to modulation of the 5-HT1A receptor measured with susceptibility enhanced contrast MRI Brain Res. 913 2001 149 155
44. J.F. Schenck The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds Med. Phys. 23 1996 815 850
45. A.J. Schwarz, T. Reese, A. Gozzi, and A. Bifone Functional MRI using intravascular contrast agents: detrending of the relative cerebrovascular (rCBV) time course Magn. Reson. Imaging 21 2003 1191 1200
46. N. Shimizu, H. Nakane, T. Hori, and Y. Hayashi CRF receptor antagonist attenuates stress-induced noradrenaline release in the medial prefrontal cortex of rats Brain Res. 654 1994 145 148
47. A.C. Silva, W. Zhang, D.S. Williams, and A.P. Koretsky Multi-slice MRI of rat brain perfusion during amphetamine stimulation using arterial spin labeling Magn. Reson. Med. 33 1995 209 214
48. E.A. Stein, J. Pankiewicz, H.H. Harsch, J.-K. Cho, S.A. Fuller, and R.G. Hoffmann Nicotine-induced limbic cortical activation in the human brain: a functional MRI study Am. J. Psychiat. 155 1998 1009 1015
49. T. Unger, S. Carolus, G. Demmert, D. Ganten, R.E. Lang, and C. Maser-Gluth P induces a cardiovascular defense reaction in the rat: pharmacological characterization Circ. Res. 63 1988 812 820
50. O. Von Bohlen, and R. Dermietzel Neurotransmitters and Neuromodulators 2002 Wiley/VCH Berlin
51. R.M. Weisskoff, C.S. Zuo, J.L. Boxerman, and B.R. Rosen Microscopic susceptibility variation and transverse relaxation: theory and experiment Magn. Reson. Med. 31 1994 601 610
52. H. Xu, S.-J. Li, J. Bodurka, X. Zhao, Z.-X. Xi, and E.A. Stein Heroin-induced neuronal activation in rat brain assessed by functional MRI NeuroReport 11 2000 1085 1092
53. Z. Zhang, A.H. Andersen, M.J. Avison, G.A. Gerhardt, and D.M. Gash Functional MRI of apomorphine activation of the basal ganglia in awake rhesus monkeys Brain Res. 852 2000 290 296